These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18376127)

  • 1. Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers.
    Ringman JM; Romano JD; Medina LD; Rodriguez-Agudelo Y; Schaffer B; Varpetian A; Ortiz F; Fitten LJ; Cummings JL; Baloh RW
    Dement Geriatr Cogn Disord; 2008; 25(4):380-4. PubMed ID: 18376127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.
    Taddei K; Fisher C; Laws SM; Martins G; Paton A; Clarnette RM; Chung C; Brooks WS; Hallmayer J; Miklossy J; Relkin N; St George-Hyslop PH; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(7):776-81. PubMed ID: 12192622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
    Scacchi R; Gambina G; Moretto G; Corbo RM
    Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer's disease. Present and future role of genetics].
    Roks G
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population.
    Albani D; Roiter I; Artuso V; Batelli S; Prato F; Pesaresi M; Galimberti D; Scarpini E; Bruni A; Franceschi M; Piras MR; Confaloni A; Forloni G
    Neurobiol Aging; 2007 Nov; 28(11):1682-8. PubMed ID: 16952411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
    Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
    J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.
    Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K
    Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.
    Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J
    Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) study.
    Carson AP; Rose KM; Sanford CP; Ephross SA; Stang PE; Hunt KJ; Brown CA; Szklo M
    Headache; 2004 Jan; 44(1):20-8. PubMed ID: 14979879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
    Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
    Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation.
    Lindquist SG; Nielsen JE; Stokholm J; Schwartz M; Batbayli M; Ballegaard M; Erdal J; Krabbe K; Waldemar G
    J Neurol Sci; 2008 May; 268(1-2):124-30. PubMed ID: 18187157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in genetic testing for Alzheimer's disease.
    Howard KL; Filley CM
    Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test].
    Tirado V; Muñoz C; Aguirre C; Pineda DA; Lopera F
    Rev Neurol; 2004 Aug 16-31; 39(4):322-6. PubMed ID: 15340889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic paraparesis.
    Raman A; Lin X; Suri M; Hewitt M; Constantinescu CS; Phillips MF
    J Neurol Sci; 2007 Sep; 260(1-2):78-82. PubMed ID: 17507029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers in persons with preclinical familial Alzheimer disease.
    Ringman JM; Younkin SG; Pratico D; Seltzer W; Cole GM; Geschwind DH; Rodriguez-Agudelo Y; Schaffer B; Fein J; Sokolow S; Rosario ER; Gylys KH; Varpetian A; Medina LD; Cummings JL
    Neurology; 2008 Jul; 71(2):85-92. PubMed ID: 18509095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
    Blom ES; Viswanathan J; Kilander L; Helisalmi S; Soininen H; Lannfelt L; Ingelsson M; Glaser A; Hiltunen M
    Eur J Hum Genet; 2008 Feb; 16(2):171-5. PubMed ID: 18043715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis.
    Hattori S; Sakuma K; Wakutani Y; Wada K; Shimoda M; Urakami K; Kowa H; Nakashima K
    Neurosci Lett; 2004 Sep; 368(3):319-22. PubMed ID: 15364419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
    Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
    Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
    Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.